HB 2060

  • Tennessee House Bill
  • 113th Regular Session (2023-2024)
  • Introduced in House Jan 25, 2024
  • House
  • Senate
  • Governor

Drugs, Prescription - As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.

Votes


Actions


May 09, 2024

House

Comp. became Pub. Ch. 808

Apr 11, 2024

House

Sponsor(s) Added.

House

Comp. SB subst.

Apr 04, 2024

House

H. Placed on Regular Calendar for 4/11/2024

Apr 03, 2024

House

Placed on cal. Calendar & Rules Committee for 4/4/2024

Mar 27, 2024

House

Rec. for pass. if am., ref. to Calendar & Rules Committee

Mar 20, 2024

House

Placed on cal. Health Committee for 3/27/2024

House

Rec for pass if am by s/c ref. to Health Committee

Mar 13, 2024

House

Placed on s/c cal Health Subcommittee for 3/19/2024

Mar 12, 2024

House

Action Def. in s/c Health Subcommittee to 3/19/2024

Mar 06, 2024

House

Placed on s/c cal Health Subcommittee for 3/12/2024

Jan 30, 2024

House

Assigned to s/c Health Subcommittee

Jan 29, 2024

House

P2C, ref. to Health Committee

Jan 25, 2024

House

Intro., P1C.

Jan 24, 2024

House

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF
Amendment HA0850 PDF
Amendment SA0702 PDF

Related Documents

Document Format
Fiscal Memo for HA0850 (15859)
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.